T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services

The State of New Jersey, through the Division of Purchase and Property on behalf of the Department of Human Services, is soliciting quotes for the procurement of FDA-approved Naloxone 4mg nasal spray. The contract requires the supplier to provide the medication in cases containing twelve two-dose cartons. A key operational requirement is the development of a process or application, such as a website, to allow program staff to submit daily orders from Monday through Friday. The award will be granted to the lowest priced quote that meets all mandatory requirements, based on a firm, fixed unit price per two-dose carton. Logistics and performance standards are stringent, requiring orders to be processed and shipped within 24 calendar hours of receipt and delivered to eligible entities within two business days. Funding for this initiative is provided by the State Opioid Response grant. Contractors must comply with FDA labeling and packaging requirements, New Jersey's Worker and Community Right to Know Act for hazardous substances, and standard state regulations including the New Jersey Prevailing Wage Act and Buy American requirements. Invoicing is conducted monthly via email and must include detailed shipping data and purchase order numbers, with the option for payment via MasterCard procurement cards. Submissions must be made electronically through the NJSTART system and include essential documentation such as the Offer and Acceptance Page, Ownership Disclosure Form, and a Specification Conformance Form. Bidders are evaluated on their technical ability to complete the scope of work and their price competitiveness. Additionally, the state may require a performance bond and reserves the right to inspect the bidder's facilities prior to the award.